Jun 13, 2026 09:00AM
Jun 13, 2026 09:00AM
Jun 1, 2026 05:00AM
Jun 1, 2026 05:00AM
May 29, 2026 07:00AM
May 29, 2026 07:00AM
May 22, 2026 09:15AM Agios receives European approval for PYRUKYND to treat thalassemia
May 22, 2026 09:15AM
May 12, 2026 09:32AM
May 12, 2026 09:31AM
May 12, 2026 09:30AM
May 12, 2026 09:30AM
Apr 29, 2026 06:30AM
Apr 21, 2026 06:41AM Agios Pharma (AGIO) PT Lowered to $50 at H.C. Wainwright
Mar 31, 2026 01:08PM
Mar 31, 2026 08:54AM
Mar 31, 2026 08:33AM
Mar 31, 2026 07:01AM
Mar 31, 2026 07:00AM
Mar 2, 2026 07:00AM
Feb 12, 2026 11:40AM Agios Pharma (AGIO) PT Raised to $39 at Truist Securities
Feb 12, 2026 06:30AM
Jan 12, 2026 07:03AM
Jan 12, 2026 07:00AM
Dec 26, 2025 07:01AM
Dec 24, 2025 12:28PM
Dec 23, 2025 07:45PM
Dec 23, 2025 07:45PM U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
Dec 9, 2025 06:56AM
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM
Nov 25, 2025 07:31AM
Nov 20, 2025 06:19AM
Nov 19, 2025 01:53PM
Nov 19, 2025 07:00AM Agios reports mixed results from sickle cell disease drug trial
Nov 19, 2025 07:00AM
Nov 3, 2025 09:01AM
Oct 30, 2025 06:30AM
Oct 17, 2025 08:01AM
Oct 17, 2025 08:00AM
Sep 5, 2025 06:44AM
Sep 5, 2025 05:02AM Goldman Sachs on Agios Pharma (AGIO): 'we see a favorable risk-benefit profile'
Sep 4, 2025 12:08PM
Sep 4, 2025 10:23AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 5, 2025 06:34AM
Aug 4, 2025 04:01PM
Aug 4, 2025 04:01PM Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
Aug 4, 2025 01:59PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All